RNU6-138P

Across TCGA pan-cancer cohorts, RNU6-138P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated RNU6-138P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RNU6-138P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-138P expression acts as an unfavorable survival marker.

STAD, KIRC, and THCA are the cancer types where RNU6-138P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	II,III,IV	0.554	0.701	.009	72	view →
KIRC	DFS	Tertile	IV	0.188	0.629	.005	66	view →
THCA	OS	Tertile	All	0.567	0.942	<.001	63	view →
PAAD	OS	Tertile	II,III,IV	0.213	0.556	.014	36	view →
TGCT	OS	Tertile	All	0.694	0.968	.004	36	view →
KIRP	DFS	Tertile	II,III,IV	0.038	0.783	<.001	36	view →
BLCA	DFS	Tertile	IV	0.188	0.480	.003	18	view →
SKCM	OS	Tertile	III,IV	0.430	0.809	.009	18	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

RNU6-138P–STAD (OS)

Open the STAD breakdown →